Innoviva (INVA) Net Cash Flow (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 118.70% |
| Jun 30, 2025 | 455.30% |
| Sep 30, 2024 | 73.67% |
| Jun 30, 2024 | 354.99% |
| Sep 30, 2023 | -483.26% |
| Jun 30, 2023 | 119.71% |
| Sep 30, 2022 | 48.71% |
| Jun 30, 2022 | 337.11% |
| Sep 30, 2021 | 53.52% |
| Jun 30, 2021 | -758.26% |
| Mar 31, 2021 | 115.64% |
| Dec 31, 2020 | -452.34% |
| Sep 30, 2020 | 7.98% |
| Jun 30, 2020 | -17.21% |
| Mar 31, 2020 | -29.73% |
| Dec 31, 2019 | 239.26% |
| Sep 30, 2019 | -59.64% |
| Jun 30, 2019 | 2,709.11% |
| Mar 31, 2019 | -80.19% |
| Dec 31, 2018 | 135.75% |
| Sep 30, 2018 | -164.26% |
| Jun 30, 2018 | 230.07% |
| Mar 31, 2018 | 29.01% |
| Dec 31, 2017 | -703.55% |
| Sep 30, 2017 | 133.51% |
| Jun 30, 2017 | -176.99% |
| Mar 31, 2017 | 68.37% |
| Dec 31, 2016 | 225.67% |
| Sep 30, 2016 | 49.14% |
| Jun 30, 2016 | -424.63% |
| Mar 31, 2016 | -109.20% |
| Dec 31, 2015 | 213.55% |
| Sep 30, 2015 | -943.95% |
| Jun 30, 2015 | -81.09% |
| Mar 31, 2015 | 294.89% |
| Dec 31, 2014 | 74.26% |
| Sep 30, 2014 | -206.89% |
| Jun 30, 2014 | 553.95% |
| Mar 31, 2014 | 35.75% |
| Dec 31, 2013 | -3.77% |
| Sep 30, 2013 | 59.07% |
| Jun 30, 2013 | -139.03% |
| Mar 31, 2013 | 1,084.82% |
| Dec 31, 2012 | 64.42% |
| Sep 30, 2012 | -133.29% |
| Jun 30, 2012 | 581.77% |
| Mar 31, 2012 | -69.66% |
| Dec 31, 2011 | 35.69% |
| Sep 30, 2011 | 51.20% |
| Jun 30, 2011 | -270.11% |
| Mar 31, 2011 | -115.42% |
| Dec 31, 2010 | 1,614.08% |